Paganini Hugo, Della M Paula, Muller Beatriz, Ezcurra Gustavo, Uranga Macarena, Aguirre Clarisa, Kamiya Marys, Ensinck Gabriela, Miranda M Rosa, Ciriaci Cristina, Hernández Claudia, Casimir Lidia, Rial M José, Schenonne Norma, Ronchi Estela, Rodríguez M del Carmen, Aprile Fabiana, De Ricco Catalina, Saito Viviana, Vrátnica Claudia, Pons Laura, Ernst Adriana, Morinigo Sandra, Toffoli Marcelo, Bosque Celia, Monzani Victoria, Mónaco Andrea, Pinheiro José L, López M del Pilar, Maninno Leonardo, Sarkis Claudia
Ciudad Autónoma de Buenos Aires, Hospital Juan P Garrahan, República Argentina.
Rev Chilena Infectol. 2009 Oct;26(5):406-12. Epub 2009 Nov 9.
Community-acquired methicillin-resistant Staphylococcus aureus infections (CA-MRSA) are prevalent in several countries of the world. These infections seem to differ clinically from those occurring within the health care system (HCS-MRSA).
To compare clinical characteristics of infections by CA-MRSA and HCA-MRSA in the same community.
Prospective, multicentric and comparative study. Children with clinically and microbiologically documented CA-MRSA were included.
Between 11/2006 and 11/2007, 840 infections caused by S. aureus were diagnosed. Of them 582 (68%) were community-acquired. Among these 356 (61%) were CA-MRSA. In this group, 75 (21%) were HCA-MRSA and 281 (79%) CA-MRSA. The median age was 36 months (range: 1-201). Chronic skin disease (13) and chronic disease of CNS (9) were the underlying disease predominant. Children with CA-MRSA had more frequency of previous antibiotic treatment (63 vs 34%) and previous medical consult (76 vs 52%), invasive procedures (31 vs 8%), surgery (15 vs 0.3%) and fever (94 vs 74%) (p = < 05). Children with CA-MRSA had subcutaneous abscesses (34 vs 15%) (p = < .05) more frequently. Bacteremia and sepsis rate was similar in both groups (21 vs 18%) and 17 vs 11%) respectively) (p = NS). Antibiotic resistance was more frequent in children with HCA-MRSA: Rifampin (7 vs 1%), trimethoprim-sulphametoxazole (7 vs 1%) and clindamycin (25 vs 9%) (p = < .05). Four children (5%) with HCA-MRSA infections died and 3 (1%) mCA-MRSA group (p = .05).
Children with HCA-MRSA infections more frequent antibiotic resistance than CA-MRSA should be reconsider the empiric antibiotic treatment of community-acquired infections in children in our area.
社区获得性耐甲氧西林金黄色葡萄球菌感染(CA-MRSA)在世界上几个国家中普遍存在。这些感染在临床上似乎与医疗保健系统内发生的感染(医院获得性耐甲氧西林金黄色葡萄球菌感染,HCS-MRSA)有所不同。
比较同一社区中CA-MRSA和医院获得性耐甲氧西林金黄色葡萄球菌感染(HCA-MRSA)的临床特征。
前瞻性、多中心比较研究。纳入临床和微生物学确诊为CA-MRSA的儿童。
在2006年11月至2007年11月期间,共诊断出840例由金黄色葡萄球菌引起的感染。其中582例(68%)为社区获得性感染。在这些社区获得性感染中,356例(61%)为CA-MRSA。在这一组中,75例(21%)为医院获得性耐甲氧西林金黄色葡萄球菌感染(HCA-MRSA),281例(79%)为社区获得性耐甲氧西林金黄色葡萄球菌感染(CA-MRSA)。中位年龄为36个月(范围:1 - 201个月)。慢性皮肤病(13例)和中枢神经系统慢性病(9例)是主要的基础疾病。CA-MRSA感染的儿童既往接受抗生素治疗的频率更高(63%对34%)、既往就诊频率更高(76%对52%)、侵入性操作更多(31%对8%)、手术更多(15%对0.3%)以及发热更多(94%对74%)(p = < 0.05)。CA-MRSA感染的儿童皮下脓肿更常见(34%对15%)(p = < 0.05)。两组的菌血症和败血症发生率相似(分别为21%对18%和17%对11%)(p = 无统计学差异)。医院获得性耐甲氧西林金黄色葡萄球菌感染(HCA-MRSA)的儿童抗生素耐药情况更常见:利福平(7%对l%)、甲氧苄啶 - 磺胺甲恶唑(7%对1%)和克林霉素(25%对9%)(p = < 0.05)。4例(5%)医院获得性耐甲氧西林金黄色葡萄球菌感染(HCA-MRSA)的儿童死亡,社区获得性耐甲氧西林金黄色葡萄球菌感染(mCA-MRSA)组有3例(1%)死亡(p = 0.05)。
医院获得性耐甲氧西林金黄色葡萄球菌感染(HCA-MRSA)的儿童比社区获得性耐甲氧西林金黄色葡萄球菌感染(CA-MRSA)的儿童抗生素耐药情况更常见,应重新考虑本地区儿童社区获得性感染的经验性抗生素治疗。